Biography and Research Information
OverviewAI-generated summary
Chengzhong Cai's research program investigates molecular mechanisms underlying disease and explores novel diagnostic and therapeutic strategies. His work has focused on identifying key proteins involved in cell proliferation, such as the importin beta superfamily member RanBP17, and its association with patient survival in HPV+ head and neck squamous cell carcinoma. Cai has also contributed to the development of predictive models for drug-induced cardiotoxicity, utilizing induced pluripotent stem cell-derived cardiomyocytes. Furthermore, his research extends to the application of mass spectrometry for early cancer screening, including a model for accurate prostate cancer detection through urine protein enrichment. His scholarship metrics include an h-index of 11, with 26 total publications and 404 citations. Cai has collaborated with several researchers at the National Center for Toxicological Research, including Vikrant Vijay, William B. Mattes, Katy S Papineau, and Lijun Ren.
Metrics
- h-index: 11
- Publications: 26
- Citations: 406
Selected Publications
-
Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin (2024)
Collaboration Network
Top Collaborators
Robert Mandić
Universitätsklinikum Gießen und Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
André Marquardt
University of Würzburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Philip Terhorst
Universitätsklinikum Gießen und Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Uzma Ali
Universitätsklinikum Gießen und Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Annette Nowak-Rossmann
Universitätsklinikum Gießen und Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Fiona R. Rodepeter
Philipps University of Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Thorsten Stiewe
Universities of Giessen and Marburg Lung Center (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Bernadette Wezorke
Universities of Giessen and Marburg Lung Center (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Michael Wanzel
Philipps University of Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Andreas Neff
Philipps University of Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Boris A. Stuck
Universitätsklinikum Gießen und Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Michael Bette
Philipps University of Marburg (DE)
1 shared publication
- The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Li Pang
United States Food and Drug Administration
1 shared publication
In database
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
Praful Aggarwal
Medical College of Wisconsin (US)
1 shared publication
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
Dong Wang
United States Food and Drug Administration
1 shared publication
In database
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
Similar Researchers
Based on overlapping research topics
Rayan Shuja
Hendrix College
Cancer-related molecular mechanisms research
Drug-Induced Hepatotoxicity and Protection
Molecular Biology Techniques and Applications
Jamya Pinkney
Hendrix College
Cancer-related molecular mechanisms research
Drug-Induced Hepatotoxicity and Protection
Molecular Biology Techniques and Applications
Marcelo Bigarella
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Prostate Cancer Treatment and Research
Drug-Induced Hepatotoxicity and Protection
Heba Allam
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Head and Neck Cancer Studies
Molecular Biology Techniques and Applications
Ying-Zhi Xu
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Drug-Induced Hepatotoxicity and Protection
Molecular Biology Techniques and Applications
K. C. Stine
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Cardiovascular Function and Risk Factors
Molecular Biology Techniques and Applications